AL-38583 Ophthalmic Solution for Allergic Conjunctivitis Associated Inflammation
Phase 2
Completed
- Conditions
- Allergic Conjunctivitis
- Interventions
- Drug: AL-38583 ophthalmic solution vehicle
- First Posted Date
- 2009-10-23
- Last Posted Date
- 2014-07-17
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 312
- Registration Number
- NCT01001091
Clinical Evaluation of the Causes of Contact Lens Related Dry Eye
Not Applicable
Completed
- Conditions
- Contact Lens Related Dry Eye
- Interventions
- Device: Opti-Free RepleniSHDevice: ReNu MultiPlusDevice: Contact lenses
- First Posted Date
- 2009-10-15
- Last Posted Date
- 2016-11-17
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 159
- Registration Number
- NCT00995189
- Locations
- 🇺🇸
Contact Alcon Call Center For Trial Locations, Fort Worth, Texas, United States
WALTZ - Wet Age-Related Macular Degeneration (AMD) AL-39324 Treatment Examination
Phase 2
Completed
- Conditions
- Age Related Macular Degeneration
- Interventions
- First Posted Date
- 2009-10-09
- Last Posted Date
- 2014-07-18
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 35
- Registration Number
- NCT00992563
Study of Olopatadine HCl Ophthalmic Solutions Compared to Vehicle Using the Conjunctival Allergen Challenge (CAC) Model of Acute Allergic Conjunctivitis in Japanese Subjects
Phase 3
Completed
- Conditions
- Allergic Conjunctivitis
- Interventions
- First Posted Date
- 2009-09-30
- Last Posted Date
- 2014-07-31
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 267
- Registration Number
- NCT00987272
Acute Comfort and Haze Profile of FID 114657
Not Applicable
Completed
- Conditions
- Dry Eye
- Interventions
- Other: FID 114657 ORB Preserved Ocular EmulsionOther: Soothe XP Lubricant Eye Drops
- First Posted Date
- 2009-09-24
- Last Posted Date
- 2012-02-02
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 20
- Registration Number
- NCT00983203
A Clinical Comparison of Three Contact Lens Care Systems and Their Effect on Contact Lenses
Not Applicable
Completed
- Conditions
- Contact Lenses
- Interventions
- Device: Opti-Free RepleniSH multi-purpose disinfecting solutionDevice: ReNu MultiPlus multi-purpose solutionDevice: Clear Care cleaning and disinfecting systemDevice: Lotrafilcon B contact lens (AIR OPTIX AQUA)Device: Senofilcon A contact lens (ACUVUE OASYS)Device: Comfilcon A contact lens (Biofinity)
- First Posted Date
- 2009-09-22
- Last Posted Date
- 2016-11-16
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 75
- Registration Number
- NCT00982046
- Locations
- 🇬🇧
Visioncare Research Ltd., Farnham, Surrey, United Kingdom
Safety and Efficacy of Olopatadine 0.6% and Azelastine 137 Mcg in Vasomotor Rhinitis
Phase 4
Completed
- Conditions
- Vasomotor Rhinitis
- Interventions
- First Posted Date
- 2009-09-18
- Last Posted Date
- 2011-05-10
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 129
- Registration Number
- NCT00979615
- Locations
- 🇺🇸
Contact Alcon Call Center For Trial Locations, Fort Worth, Texas, United States
Efficacy and Safety of Travoprost 0.004% Versus Tafluprost 0.0015% in Patients With Primary Open-angle Glaucoma or Ocular Hypertension
Phase 4
Completed
- Conditions
- Glaucoma
- Interventions
- First Posted Date
- 2009-08-27
- Last Posted Date
- 2012-06-20
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 51
- Registration Number
- NCT00966940
ACRYSOF® Toric NATURAL T9 Intraocular Lens (IOL)
Not Applicable
Completed
- Conditions
- Bilateral Cataract
- Interventions
- Device: ACRYSOF® Single-Piece NATURAL Toric IOL Model SN60T9 and Model SN60T8.
- First Posted Date
- 2009-08-27
- Last Posted Date
- 2017-01-09
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 15
- Registration Number
- NCT00967473
- Locations
- 🇺🇸
Alcon Call Center for Trial Locations, Fort Worth, Texas, United States
Efficacy and Safety of Adding Azarga to Prostaglandin Monotherapy
Phase 4
Completed
- Conditions
- Glaucoma
- Interventions
- Drug: Brinzolamide/Timolol Maleate Fixed Combination (AZARGA)
- First Posted Date
- 2009-08-27
- Last Posted Date
- 2016-11-21
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 47
- Registration Number
- NCT00966576
© Copyright 2025. All Rights Reserved by MedPath